In English | En español

National Cancer Institute

at the National Institutes of Health

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

Clinical Trials Search Results

Page Options

Email This Document

Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat

Popular Resources

Help Using the NCI Clinical Trials Search Form
How to Find a Cancer Treatment Trial
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary
Featured Clinical Trials Supported by NCI

View Content for:

Patients
Health Professionals

Display:

Title
Description with: Locations Eligibility
Full Trial Description
Custom

Results 1-14 of 14 for your search:

Drug:  cyproterone acetate
Find trials that include:  Any drugs shown
Trial Status:  Closed

Hide Search Criteria

Show Search Criteria

Help with Results

Select All on Page Sort by: Show Results per Page

Phase III Randomized Study of Neoadjuvant Androgen Deprivation Followed By Conformal Radiotherapy in Patients With Localized Prostate Cancer (Summary Last Modified 05/98)

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: NCRI-1104, EU-98006, UKCCCR-1104

Phase III Randomized Study of Cyproterone Acetate in Patients With Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BARR-PCA-301, NCT00005623

Phase III Immediate vs Delayed Endocrine Therapy with Zoladex and Cyproterone Acetate for Patients with pN1-3M0 Carcinoma of the Prostate

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: EORTC-30846

Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer

Phase: Phase III
Type: Treatment
Status: Completed
Age: under 80
Sponsor: Other
Protocol IDs: EORTC-22863, NCT00849082

Phase III Randomized Comparison of Orchiectomy vs Buserelin vs Buserelin/Cyproterone Acetate in Patients with Stage D Prostatic Carcinoma Previously Untreated with Chemotherapy or Endocrine Therapy (Summary Last Modified 09/88)

Phase: Phase III
Type: Treatment
Status: Closed
Age: 50 to 80
Sponsor:
Protocol IDs: EORTC-30843

Phase III Comparison of Early vs Delayed Endocrine Manipulation (Orchiectomy or LHRH Agonist Therapy) in Previously Untreated Patients with Nonmetastatic Asymptomatic Carcinoma of the Prostate

Phase: Phase III
Type: Treatment
Status: Closed
Age: 80 and under
Sponsor:
Protocol IDs: EORTC-30891

Phase III Comparison of Flutamide vs Cyproterone Acetate in Patients with Painless Metastatic Prostatic Adenocarcinoma with Favorable Prognostic Characteristics (Summary Last Modified 06/90)

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: EORTC-30892

Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 80
Sponsor: Other
Protocol IDs: CDR0000270970, FRE-FNCLCC-GETUG-12/0203, EU-20238, NCT00055731

Active Surveillance, Radical Prostatectomy, or Radiation Therapy in Treating Patients With Localized Prostate Cancer

Phase: Phase III
Type: Health services research, Treatment
Status: Closed
Age: 50 to 69
Sponsor: Other
Protocol IDs: CDR0000584897, SHEFF-PROTECT, ISRCTN20141297, EU-20802, SHEFF-HTA-96/20/99, RADCLIFFE-PROTECT, PROTECT, NCT00632983

10.

Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer

Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI, Other
Protocol IDs: PR7, CAN-NCIC-PR7, SWOG-JPR7, ICR-CTSU-JPR7, CDR0000066745, JPR7, NCT00003653

11.

A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: DR-PCA-201, NCT00196339

12.

Randomized Comparison of Orchiectomy vs DES vs Orchiectomy plus Cyproterone Acetate for Metastatic Prostatic Cancer

Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: EORTC-30805

13.

Comparative Study of Hormone Therapy with CTA, MPA, or DES for Advanced Prostatic Cancer Stages T3 and T4

Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: EORTC-30761, UICC-76091

14.

Androcur Effects on Quality of Life

Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 14166, AC0710HU, NCT00908674

Select All on Page

Help with Results

We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat

NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map